首页> 外国专利> Carboxylate compounds of noble metal catalytic high efficiency of IR, Ru, Rh, PD, Pt and Au

Carboxylate compounds of noble metal catalytic high efficiency of IR, Ru, Rh, PD, Pt and Au

机译:贵金属的羧酸盐化合物催化IR,Ru,Rh,PD,Pt和Au的高效率

摘要

The state of expression of MSH3 to determine the responsiveness of cells to treatment quimioteru00c1pico canceru00cdgenas inhibitors of PARP and lipid of platinum. Methods are disclosed for treating a patient at risk or diagnosed with colon rectal cancer.The method of the present invention determines the general expression of MSH3 cells suspected to be cells of colon rectal cancer patient and the efficacy of therapy with a genotoxic agent antineplu00e1sico for treatment of the patient, in which a decrease in overall expression of MS. H3 in the cells of the patient when compared with expression in cells MSH3 colon - retais normal.Indicates a predisposition to responsiveness to therapy genotoxic with anticancer agent, in which the therapy includes the administration of an effective amount of a genotoxic therapy with antineoplastic agent to patients.
机译:MSH3的表达状态,用于确定细胞对PARP的Quimioter,PPAR抑制剂和脂质的治疗反应。公开了用于治疗处于风险中或被诊断患有结肠直肠癌的患者的方法。本发明的方法确定了怀疑是结肠直肠癌患者的细胞的MSH3细胞的一般表达以及基因毒性药物antinepl的治疗功效用于治疗患者,其中MS的总体表达下降。与患者结肠MSH3细胞中的表达水平相比,患者细胞中的H3-正常。表明对抗癌药对基因毒性疗法有反应的易感性,其中该疗法包括将有效量的抗癌药基因毒性疗法用于治疗耐心。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号